DIABETES CARE: THE ROLE OF STEM CELL THERAPY

Welcome to our comprehensive guide on diabetes treatment, where we delve into the intricacies of current approaches and spotlight the innovative treatment approach of stem cell therapy

UNDERSTANDING DIABETES
Diabetes is a chronic metabolic disorder characterised by elevated blood glucose levels, either due to insufficient insulin production or ineffective utilisation of insulin. This condition, with its various types, poses a significant challenge to patients, impacting their daily lives and long-term health.

Type 1 Diabetes:
• Polyuria: Excessive urination, often leading to increased thirst.
• Polydipsia: Intense thirst and the need for frequent fluid intake.
• Weight Loss: Unexplained weight loss despite increased appetite.

Type 2 Diabetes:
• Fatigue: Persistent tiredness and lack of energy.
• Blurred Vision: Impaired vision due to high blood sugar affecting the lens.
• Slow Healing: Delayed wound healing and frequent infections.

Conventional diabetes management primarily involves lifestyle modifications, oral medications, and insulin therapy.

Dietary Management:
• Tailored meal plans to regulate blood sugar levels.
• Emphasis on a balanced diet, portion control, and carbohydrate monitoring.

Regular Exercise:
• Physical activity aids in weight management and improves insulin sensitivity.
• Recommendations include at least 150 minutes of moderate-intensity exercise per week.

Weight Management:
• Achieving and maintaining a healthy weight is crucial for diabetes management.
• Weight loss can contribute to improved blood sugar control.

Common Medications:
Metformin: Improves insulin sensitivity and reduces glucose production in the liver and is often prescribed as a first-line medication for type 2 diabetes.

Sulfonylureas such as Glibenclamide, Glimepiride: Stimulates insulin release from the pancreas.

DPP-4 Inhibitors such as Sitagliptin, Saxagliptin: Slows down the inactivation of incretin hormones, increasing insulin release.

SGLT2 Inhibitors such as Canagliflozin, Empaglifl: Reduces glucose reabsorption in the kidneys, increasing urinary glucose excretion.

GLP-1 Receptor Agonists such as Exenatide, Liraglutide: Increases insulin release, reduces glucagon secretion, and slows gastric emptying.

Injectable Medications:
Insulin Therapy:
• Rapid-Acting Insulin: Administered just before or after meals to control postprandial glucose levels.
• Long-Acting Insulin: Provides a baseline insulin level throughout the day.
• Amylin Analogs such as Pramlintide: Slows gastric emptying and reduces glucagon secretion.

Dual and Triple Therapy: Combining different classes of medications for enhanced efficacy.

Gene Therapy: Exploring the potential of genetic modifications to improve insulin production and sensitivity.

Artificial Pancreas: Development of closed-loop insulin delivery systems for better glucose control.

Stem cell therapy involves the precise injection of stem cells, typically derived from sources like bone marrow or adipose tissue, into the body. The primary objective is to stimulate the regeneration of damaged pancreatic tissue and enhance insulin production. This methodical intervention not only alleviates symptoms but also addresses the root cause of diabetes.

The regenerative aspect of stem cell therapy is pivotal. Stem cells exhibit the capacity not only to replace damaged or lost cells but also to stimulate the regeneration of existing tissue in the pancreas. This dual action holds the potential to not only manage symptoms but actively reverse the degenerative process, representing a paradigm shift in diabetes treatment.

Clinical outcomes of stem cell therapy vary among individuals:

Immediate Improvements:
• Some experience significant relief shortly after stem cell treatment.
• Immediate improvements may include reduced fatigue, improved appetite, and enhanced liver function.

Gradual Progress:
• Others observe ongoing progress over an extended period.
• Gradual progress may involve continued improvement in liver function, reduced inflammation, and an overall sense of well-being.

This nuanced response emphasises the need for personalised care and ongoing monitoring. Stem cell therapy represents a paradigm shift, offering not only symptom management but the potential for active pancreatic regeneration, marking a new era in diabetes care.

Behind this innovative approach is our expert team of international doctors and collaborative research at Kantsugi. Rooted in medical expertise and guided by our unwavering medical care, we are committed to cutting-edge advancements in diabetes care, weaving together the principles of regenerative medicine and the fundamentals of client-centric care.

WHAT TO EXPECT
Our commitment to providing exceptional diabetes care involves several key aspects that define the Kantsugi experience.

Personalised Care:
Treatment plans at Kantsugi are designed with the individual in mind. We understand that each person’s experience with chronic pain is unique, requiring personalised interventions for optimal outcomes.

Comprehensive Consultation:
Thorough assessments of medical history and symptoms form the foundation of our approach. In-depth discussions address patient concerns and expectations, fostering acollaborative and informed healthcare journey.

Cutting-Edge Approach:
Kantsugi stands at the forefront of medical advancements. We utilise the latest in stem cell therapy and regenerative medicine to ensure that our patients benefit from the most innovative and effective treatments available.

Holistic Support:
Beyond symptom management, our focus extends to overall well-being. Supportive care at Kantsugi enhances the quality of life for individuals living with diabetes, fostering a sense of empowerment and resilience.

CONSULTATION PROCESS
Our experienced team of medical professionals will conduct a thorough assessment, considering the unique medical history and symptoms of each patient. This in-depth consultation aims to tailor the stem cell therapy approach to individual needs.

TREATMENT DURATION
The duration of stem cell therapy for diabetes patients can vary. While some individuals may experience immediate improvements shortly after treatment, others may observe gradual progress over an extended period. This variability underlines the importance of ongoing monitoring and personalised care to ensure the most effective and beneficial outcomes.

For Experts: Research and White Papers
For experts in the field seeking more information on current research and white papers related to stem cell therapy for diabetes, please visit our Research and Publications section. Stay informed about the latest advancements and scientific insights in regenerative medicine.